Reactions 1704, p311 - 2 Jun 2018 Development of posaconazole cross-resistance in invasive pulmonary aspergillosis: case report A patient [age and sex not stated] developed development of posaconazole cross-resistance in invasive pulmonary aspergillosis (IPA) during treatment with posaconazole [route, dosage, time to reaction onset not stated]. The patient, who had been receiving posaconazole prophylaxis for prolonged time due to chronic graft-versus-host disease, showed posaconazole cross-resistance. The MIC data showed itraconazole resistant IPA. Author comment: "Posaconazole cross-resistance in patients with prolonged use of posaconazole prophylaxis due to chronic graft-versus-host diseases"."Antifungal resistance was not common, but possible". Cho SY, et al. Identification using panfungal PCR and susceptibility testing for Aspergillus clinical isolates from hematologic patients with invasive pulmonary aspergillosis. International Journal of Antimicrobial Agents 50 (Suppl. 1): S119, Sep 2017 [abstract] - South Korea 803323818 0114-9954/18/1704-0001/$14.95 Adis © 2018 Springer International Publishing AG. All rights reserved Reactions 2 Jun 2018 No. 1704
Reactions Weekly – Springer Journals
Published: Jun 2, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
All the latest content is available, no embargo periods.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud